The convergence of advances in medical science, human biology, data science, and
technology has enabled the generation of new insights into the phenotype known as …

The Precision Medicine in Diabetes Initiative (PMDI) was launched in 2018 by the American
Diabetes Association (ADA) in collaboration with the European Association for the Study of …

Rapid advances in technology and data science have the potential to improve the precision
of preventive and therapeutic interventions, and enable the right treatment to be …

Precision medicine is part of the logical evolution of contemporary evidence-based medicine
that seeks to reduce errors and optimize outcomes when making medical decisions and …

The precision medicine approach of tailoring treatment to the individual characteristics of
each patient or subgroup has been a great success in monogenic diabetes subtypes, MODY …

First envisioned by early diabetes clinicians, a person-centred approach to care was an
aspirational goal that aimed to match insulin therapy to each individual's unique …

Diabetes has become a major burden of healthcare expenditure. Diabetes management
following a uniform treatment algorithm is often associated with progressive treatment failure …

The detailed characterization of human biology and behaviors is now possible at scale
owing to innovations in biomarkers, bioimaging, and wearable technologies;“big data” from …

The study of type 2 diabetes has been driven by advances in human genetics, epigenetics,
biomarkers, mechanistic studies, and large clinical trials, enabling new insights into disease …

Abstract The Precision Medicine Initiative defines precision medicine as 'an emerging
approach for disease treatment and prevention that takes into account individual variability …